TriSalus Life Sciences, Inc.
Total Trades
17
Buys
6
Sells
4
Largest Trade
N/A
Insiders
8
Institutional Funds
48
Inst. Value
$1M+
Activist Filings
23
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Cox Bryan F. | Chief of Research | SELL | $15K–$50K | 5K | $5.18 | May 21, 2025 |
| Cox Bryan F. | Chief of Research | GRANT | $50K–$100K | 16K | $5.18 | May 21, 2025 |
| Devlin Jodi | Chief of Clinical … | SELL | $15K–$50K | 5K | $5.18 | May 21, 2025 |
| Devlin Jodi | Chief of Clinical … | GRANT | $100K–$500K | 24K | $5.18 | May 21, 2025 |
| Marshak Richard | Chief Commercial O… | GRANT | $100K–$500K | 21K | $5.18 | May 21, 2025 |
| Marshak Richard | Chief Commercial O… | SELL | $15K–$50K | 7K | $5.18 | May 21, 2025 |
| Stevens Jennifer | Chief Regulatory O… | GRANT | $100K–$500K | 28K | $5.18 | May 21, 2025 |
| Stevens Jennifer | Chief Regulatory O… | SELL | $15K–$50K | 9K | $5.18 | May 21, 2025 |
| Szela Mary T | CEO AND PRESIDENT | BUY | $50K–$100K | 10K | $5.15 | Jan 31, 2025 |
| Szela Mary T | CEO AND PRESIDENT | GRANT | N/A | 40K | — | Jan 29, 2025 |
| Szela Mary T | CEO AND PRESIDENT | BUY | $50K–$100K | 10K | $5.27 | Jan 29, 2025 |
| Murphy Sean | Chief Manuf | GRANT | N/A | 13K | — | Jan 29, 2025 |
| Murphy Sean | Chief Manuf | BUY | $100K–$500K | 30K | $5.24 | Jan 29, 2025 |
| Young James Emmett | CFO | BUY | $100K–$500K | 24K | $5.40 | Jan 29, 2025 |
| Young James Emmett | CFO | GRANT | N/A | 13K | — | Jan 29, 2025 |
| Wahlstrom Mats | Director | BUY | $15K–$50K | 5K | $4.55 | Nov 25, 2024 |
| Wahlstrom Mats | Director | BUY | $15K–$50K | 11K | $4.39 | Nov 23, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 48 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Nantahala Capital Management, LLC | 2.1M | $1M+ | SH |
| AWM Investment Company, Inc. | 1.2M | $1M+ | SH |
| Wealthcare Advisory Partners LLC | 644K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 643K | $1M+ | SH |
| Alyeska Investment Group, L.P. | 408K | $1M+ | SH |
| STATE STREET CORP | 265K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 100K | $500K+ | SH |
| Empire Financial Management Company, LLC | 72K | $500K+ | SH |
| CWA Asset Management Group, LLC | 72K | $500K+ | SH |
| WHITE PINE CAPITAL LLC | 59K | $100K–$500K | SH |
| BARCLAYS PLC | 48K | $100K–$500K | SH |
| Squarepoint Ops LLC | 44K | $100K–$500K | SH |
| MSD Partners, L.P. | 40K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 39K | $100K–$500K | SH |
| Nuveen, LLC | 37K | $100K–$500K | SH |
| Laird Norton Wetherby Trust Company, LLC | 35K | $100K–$500K | SH |
| MORGAN STANLEY | 30K | $100K–$500K | SH |
| DEUTSCHE BANK AG\ | 24K | $100K–$500K | SH |
| Connecticut Wealth Management, LLC | 22K | $100K–$500K | SH |
| MetLife Investment Management, LLC | 18K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Nantahala Capital Management, LLC
SC 13G/A · Nov 14, 2025
4.1%
2.0M shares
SC 13G · Nov 3, 2025
6.8%
3.4M shares
SC 13G/A · Aug 19, 2025
5.2%
2.0M shares
SC 13G · Aug 18, 2025
0.1%
2.0M shares
Nantahala Capital Management, LLC
SC 13G · Aug 14, 2025
5.3%
2.0M shares
SC 13D/A · Aug 4, 2025
14.0%
7.0M shares
SC 13D/A · Aug 1, 2025
6.0%
3.0M shares
SC 13D/A · May 2, 2025
20.5%
6.7M shares
SC 13G · Jan 10, 2025
6.6%
2.0M shares
Lombard International Assurance S.A.
SC 13G · Jan 10, 2025
0.0%
0 shares
SC 13D/A · Dec 19, 2024
9.0%
2.8M shares
SC 13D/A · Dec 19, 2024
20.9%
6.5M shares
SC 13G · Dec 4, 2024
6.2%
1.9M shares
Lombard International Assurance S.A.
SC 13G · Oct 21, 2024
6.7%
2.0M shares
Unique Diamond Investments Limited
SC 13G · Aug 29, 2023
5.9%
1.5M shares
Lombard International Assurance S.A.
SC 13G · Aug 23, 2023
5.2%
1.4M shares
SC 13G · Aug 22, 2023
5.3%
1.4M shares
SC 13D · Aug 21, 2023
8.2%
2.3M shares
SC 13G · Aug 21, 2023
5.6%
1.5M shares
SC 13D · Aug 21, 2023
10.4%
2.7M shares
SC 13G · Aug 21, 2023
5.3%
1.4M shares
SC 13D · Aug 21, 2023
24.1%
6.4M shares
SC 13G/A · Jan 28, 2022
6.8%
1.7M shares